COMPUESTOS PARA ANULAR RESISTENCIAS A MEDICAMENTOS

LA INVENCION DESTACA NUEVOS DERIVADOS PEPTIDICOS DENOMINADOS REVERSINAS, Y POSIBILITA SU UTILIZACION EN UN METODO DE REDUCCION DE LA ACTIVIDAD DE LA PROTEINA TRANSPORTADORA DE MULTIPLES MEDICAMENTOS MDR1, CON EL OBJETO DE EVITAR LA RESISTENCIA A MULTIPLES MEDICAMENTOS EN MAMIFEROS. LOS DERIVADOS PEP...

Full description

Saved in:
Bibliographic Details
Main Authors MEZO, IMRE, TEPLAN, ISTVAN, CSUKA, ORSOLYA, SARKADI, BALAZS, MAGOCSI, MARIA, SEPRODI, JANOS
Format Patent
LanguageSpanish
Published 16.08.2000
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:LA INVENCION DESTACA NUEVOS DERIVADOS PEPTIDICOS DENOMINADOS REVERSINAS, Y POSIBILITA SU UTILIZACION EN UN METODO DE REDUCCION DE LA ACTIVIDAD DE LA PROTEINA TRANSPORTADORA DE MULTIPLES MEDICAMENTOS MDR1, CON EL OBJETO DE EVITAR LA RESISTENCIA A MULTIPLES MEDICAMENTOS EN MAMIFEROS. LOS DERIVADOS PEPTIDICOS, TIENEN LA FORMULA (I) X{SUP,1}{SUB,N}-X{SUP,2}-X{SUP,3}(X{SUP,4}){SUB,N}-X{SUP,5}, DONDE N ES 0 O 1, Y CADA N ES IGUAL O DISTINTO; X{SUP,1} ES BOC, BOC-ASU, Z-ASU, BENCILOXICARBONILO, GLU(OBCZL)-OBZL, TRP-OME, TRP-PHE-OME, PHE-TRP-OME, PHE-PHE-OTBU, TRP-TRP-OTBU, INDOLOACETILO, BENZOILO, UNA ALQUILAMINA DE 1-4 CARBONOS, DIBENCILAMIDA, TRIPTAMIDA, 1-AMINO-ADAMANTINO, AMINOMETILCICLOHEXANO, INDOLINA, FENILMETILAMIDA O DICICLOHEXILAMIDA; X{SUP,2} ES GLU(OBZL, ASP(OBZL), SUCCINILO, O,O-DIBENZOLITARTAROILO, DIFENOILO, MUCONILO, THX, CPA, ASU, NAL, PEN, PHG, DBT, LYS(BOC), LYS(Z), CYS(BZL), THR(BZL), GLU(OTBU), TRET-LEU, LEU, NLE, PRO, PHE, TYR(BZL), O SER(BAL); X{SUP,3} ES ASP, ASU, LYS, GLU,TRP, THX, CPA, NAL, PEN, PHG, DBT, GLU(OTBU), TERT-LEU, LEU, NLE, PRO, TYR, PHE O TYR(BZL); X{SUP,4} ES BOCGLU(OBZL), GLU(OBZL), ASU, OBCL, BZL, BOC, BOC-LYS(BOC), ZGLU(OTBU), ASP(OBZL), ASP(OBZL)-OBZL, BENCILOXICARBONILO, O(CICLO-HEXILO), ESTER DE FLUORENILMETILO, GLU(OTBU), GLU(OTBU)OBZL, 1-AMINO-ADAMANTINO, AMINOMETILCICLOHEXANO, INDOLINA, FENILETLAMINA, O DICICLOHEXILAMIDA; Y X{SUP,5} ES OME, OBZL, OTBU, PHE-OME, -O-(CICLOHEXILO), TRP-OME, (CLOROFENIL)ISOBUTILAMIDA, ESTER DEE FLUORENILMETILO, ONP, 1-AMINOADAMANTANO, AMINOMETILCICLOHEXANO, INDOLINA, FENILETILAMIDA, O DICICLOHEXILAMIDA. The invention features novel peptide derivatives called Reversins, and provides for their use in a method of reducing the activity of the multi-drug transporter protein MDR1 in order to overcome multidrug resistance in a mammal. The peptide derivatives are of the formula (I) X1n-X2-X3(X4)n-X5, wherein n is 0 or 1, and each n is the same or different; X1 is BOC, BOC-Asu, Z-Asu, benzyloxycarbonyl, Glu(OBzl)-OBzl, Trp-OMe, Trp-Phe-OMe, Phe-Trp-OMe, Phe-Phe-OtBu, Trp-Trp-OtBu, indoloacetyl, benzoyl, an alkylanine of 1-4 carbons, dibenzylamide, tryptamide, 1-amino-adamantine, aminomethylcyclohexane, indoline, phenylethylamide or dicyclohexylamide; X2 is Glu(OBzl), Asp(OBzl), succinyl, O,O-dibenzoyltartaroyl, diphenoyl, muconyl, Thx, Cpa, Asu, Nal, Pen, Phg, Dbt, Lys(BOC), Lys(Z), Cys(Bzl), Thr(Bzl), Glu(OtBu), tert.-Leu, Leu, Nle, Pro, Phe, Tyr(Bzl), or Ser(Bal); X3 is Asp, Asu, Lys, Glu, Trp, Thx, Cpa, Nal, Pen, Phg, Dbt, Glu(OtBu), tert.-Leu, Leu, Nle, Pro, Tyr, Phe, or Tyr(Bzl); X4 is BOC-Glu(OBzl), Glu(OBzl), Asu, OBzl, Bzl, BOC, BOC-Lys(BOC), Z-Glu(OtBu), Asp(OBzl), Asp(OBz)-OBzl, benzyloxycarbonyl, O-(cyclo-hexyl), fluorenylmethyl ester, Glu(OtBu), Glu(OtBu)-OBzl, 1-amino-adamantine, aminomethylcyclohexane, indoline, phenylethylarnide, or dicyclohexylamide; and X5 is OMe, OBzl, OtBu, Phe-OMe, -O-(cyclohexyl), Trp-OMe, (chlorophenyl)-isobutylamide, fluorenylmethyl ester, ONp, 1-aminoadamantane, aminomethylcyclohexane, indoline, phenylethylamide, or dicyclohexylamide.
Bibliography:Application Number: ES19940915684T